We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Innovative Magnetic Platform Expedites Gallbladder Removal

By HospiMedica International staff writers
Posted on 31 Aug 2016
Print article
Image: The Levita magnetic surgical system (Photo courtesy of Levita Magnetics).
Image: The Levita magnetic surgical system (Photo courtesy of Levita Magnetics).
A novel magnetic surgery system grasps and retracts tissue and organs in laparoscopic cholecystectomy procedures, facilitating access and visualization of the surgical site.

The Levita Magnetic Surgical System is comprised of a magnetic grasper device with a detachable tip and a magnetic controller. The grasper is inserted into the abdominal cavity via a small incision; once the magnetic tip reaches the gallbladder, the surgeon deploys it, attaching it to the body and the fundus of the gallbladder, and removes the grasper. The surgeon then uses the magnetic controller to maneuver and lift the gallbladder via a magnetic field, without damaging the abdominal wall. Once near the opening, the grasper is re-inserted to retrieve the magnetic tip and attached gallbladder.

The system reduces complications during surgery--such as organ injuries, bleeding, or pain--and also provides a better procedure for the surgeon, with less instrument crowding and less scarring for the patient. The Levita Magnetic Surgical System is a product of Levita Magnetics (San Mateo, CA, USA), and has been approved by the U.S. Food and Drug Administration (FDA) for laparoscopic cholecystectomy in patients within a body mass index (BMI) range of 20- 34 kg/m2.

“We are proud to be the pioneers of magnetic surgery. Having been a minimally invasive surgeon for over 10 years, I understand the complexity my peers face when trying to gain proper access to organs,” said surgeon Alberto Rodriguez-Navarro, MD, founder and CEO of Levita Magnetics. “Our goal at Levita is to equip surgeons with the technology they need to make surgery easier and less invasive, while enabling improved patient outcomes.”

In traditional laparoscopic cholecystectomy, four incisions are made in the abdomen: one on the rim of the navel, one beneath the navel, and two beneath the navel and to the right. A laparoscope and surgical instruments are passed into the interior of the abdomen to aid the surgeon in removal of the gallbladder. The new magnetic system reduces the number of incisions needed.

Related Links:
Levita Magnetics

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Surgial Headlight
MedLED Chrome

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.